ARTICLE | Company News
NeuroSearch, Shire Pharmaceuticals Group plc deal
September 4, 2001 7:00 AM UTC
The partners will seek a licensee for NS1209, a glutamate AMPA antagonist neuroprotectant that is in Phase I testing to treat brain damage following stroke. ...